TRAF2 and Myocardial fibrosis: Transgenic mice overexpressing TRAF2 driven by MHC promoter (MHC-TRAF2HC demonstrated the symptoms of progressive cardiac hypertrophy with increased myocardial fibrosis even after 12 weeks (Divakaran et al., 2013).